Janet Marie Trowbridge MD PhD (She/Her)
Acne & Rosacea, Pediatric Dermatology
Medical Dermatologist/Consultant
Join to View Full Profile
16740 76th Ave WEdmonds, WA 98026
Phone+1 206-295-6724
Dr. Trowbridge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Janet Trowbridge is a medical dermatologist and consultant based in Edmonds, WA. She holds an MD and a PhD from NYU. She completed her residency in dermatology, an internship in internal medicine and a post-doctoral fellowship in skin biology at the University of California (San Diego) Medical Center. She has served as the Medical Director for Last Stage Clinical Development at Seagen and then Pfizer from 2020 until 2024. Her clinical experience includes medical dermatology including cutaneous malignancies. Her research interests include developing new drugs for dermatologic, oncologic and inflammatory conditions and characterizing and managing cutaneous adverse events of targeted therapies.
Education & Training
University of California (San Diego) Medical CenterResidency, Dermatology, 2002 - 2005- UC San Diego Medical Center - HillcrestPost-Doctoral Fellowship, 2000 - 2002
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1999 - 2000
New York University School of MedicineClass of 1999
NYUPhD, Biology, 1994 - 1998
Certifications & Licensure
WA State Medical License 2006 - 2027
CA State Medical License 2002 - 2006
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 192 citationsEnfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trialEvan Y. Yu, Daniel P. Petrylak, Peter H. O'Donnell, Jae-Lyun Lee, Michiel S. van der Heijden
The Lancet. Oncology. 2021-06-01 - 57 citationsThe Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor GrowthAmanda S. Büchau, Shin Morizane, Janet M. Trowbridge, Jürgen Schauber, Paul Kotol
Journal of Immunology. 2010-01-01 - 18 citationsInnate Immunity: A Cutaneous PerspectiveHeidi Goodarzi, Janet M. Trowbridge, Richard L. Gallo
Clinical Reviews in Allergy & Immunology. 2007-11-09
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
